Navigation Links
West Appoints Two Directors and Announces Second Quarter 2011 Dividend
Date:2/24/2011

LIONVILLE, Pa., Feb. 24, 2011 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors increased the size of the Board to twelve and appointed two new directors, Mr. Mark A. Buthman and Mr. Douglas A. Michels. Each of their terms are effective immediately and will expire at the 2011 Annual Meeting of Shareholders, when they will stand for election to serve for the balance of their terms. The appointments anticipate the August 2011 retirement of directors John P. Neafsey and Geoffrey F. Worden under the Board's retirement policy.

Mr. Buthman, 50, is Senior Vice President and Chief Financial Officer of Kimberly-Clark Corporation (NYSE: KMB), a global producer of branded products for the consumer, professional and healthcare markets.  Mr. Michels, 54, is President, Chief Executive Officer and a member of the board of directors of Orasure Technologies, Inc. (Nasdaq: OSUR), a clinical diagnostic-products company based in Bethlehem, PA.

"We are pleased to welcome two highly qualified corporate executives to our diverse and independent board," said Donald E. Morel, Jr., Ph.D., West's Chairman and Chief Executive Officer in announcing the appointments.  "Their unique backgrounds will help to maintain an important balance of operational, financial and healthcare expertise on the Board. We appreciate the substantial commitments that our directors make to the Company and its shareholders, and our continued ability to attract strong and talented independent directors reflects well on our Company and its prospects."  

The Board also approved payment of the second-quarter 2011 cash dividend of $0.17 per share. The dividend will be paid on May 4, 2011 to shareholders of record on April 20, 2011.

About West

West is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at www.westpharma.com.

Contacts:

West Pharmaceutical Services, Inc.

Michael A. Anderson

Vice President and Treasurer

(610) 594-3345

Investors and Financial Media:

Westwicke Partners

John Woolford/Stefan Loren

(443) 213-0506/0507




'/>"/>
SOURCE West Pharmaceutical Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Masters Pharmaceutical, Inc. Appoints Wayne A. Corona to President and Chief Operating Officer
2. Siemens Appoints Overhage as New Chief Medical Informatics Officer
3. MAP Pharmaceuticals Appoints Scott R. Ward as Chairman of the Board of Directors
4. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
5. Mercator MedSystems Appoints Neil Desai, Ph.D., to Board of Directors
6. Simcere Pharmaceutical Group Appoints Industry Veteran Mr. Hong Zhao as Executive Vice President of Sales and Marketing
7. Plato BioPharma, Inc Appoints New Board Member
8. Cayenne Medical, Inc. Appoints David B. Springer President & CEO
9. SYNARC Appoints Ciaran Cooper as Vice President, Business Development
10. Onyx Pharmaceuticals Appoints Bill Ringo to Board of Directors
11. Unilife Appoints Dr. Ramin Mojdeh as Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):